Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Intelligent Bio Solutions ( (INBS) ) is now available.
On October 16, 2025, Intelligent Bio Solutions Inc. held its annual stockholder meeting where an amendment was approved to effect a reverse stock split. The company’s board decided on a 1-for-10 reverse stock split, which was filed on December 12, 2025, and became effective on December 15, 2025. This move reduced the number of outstanding shares from approximately 9.6 million to 960,000, with trading on a split-adjusted basis beginning on December 16, 2025. The reverse stock split aims to consolidate shares without altering the overall equity structure, except for cash payments in lieu of fractional shares.
The most recent analyst rating on (INBS) stock is a Hold with a $0.70 price target. To see the full list of analyst forecasts on Intelligent Bio Solutions stock, see the INBS Stock Forecast page.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance and poor valuation metrics, which are significant concerns. However, positive corporate events, such as new customer acquisitions and strategic FDA clearance plans, provide some optimism for future growth. The technical analysis suggests a bearish trend, further weighing down the score.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company that provides intelligent, rapid, non-invasive testing solutions. The company is known for its Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat analysis for drug testing. This system is designed to be hygienic and cost-effective, offering results in under ten minutes. The company’s primary market focus includes safety-critical industries such as construction, manufacturing, transport, logistics, mining, drug treatment organizations, and coroners.
Average Trading Volume: 287,776
Technical Sentiment Signal: Sell
Current Market Cap: $6.9M
For an in-depth examination of INBS stock, go to TipRanks’ Overview page.